Fig. 3. Median plasma concentration-time profiles of rocuronium after administration of rocuronium (0.6 mg/kg) followed by (  A ) placebo or (  B ) 0.5 mg/kg sugammadex, (  C ) 1.0 mg/kg sugammadex, (  D ) 2.0 mg/kg sugammadex, or (  E ) 4.0 mg/kg sugammadex stratified by age group (all subjects pharmacokinetically evaluable group with a measurable reading at individual time points).